Read more stories about
Incubators and R&D >>

MATR Sponsor:


MATR Supporters:

F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment

July 13, 2017View for printing

A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient's own cells to fight cancer, transforming them into what scientists call "a living drug" that powerfully bolsters the immune system to shut down the disease.

By DENISE GRADY

Full Story: https://www.nytimes.com/2017/07/12/he ... ef=headline
No reader comments so far. Be the first to comment by clicking the button below.





Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.


E-mail this page to a friend!